Results of paclitaxel (day 1 and 8) and carboplatin given on every three weeks in advanced (stage III-IV) non-small cell lung cancer

<p>Abstract</p> <p>Background</p> <p>Both paclitaxel (P) and carboplatin (C) have significant activity in non-small cell lung cancer (NSCLC). The weekly administration of P is active, dose intense, and has a favorable toxicity profile. We retrospectively reviewed the da...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Salepci Taflan, Ozkan Alper, Turken Orhan, Hatabay Nilgun F, Gumus Mahmut, Turhal Nazim S, Yumuk Perran F, Aliustaoglu Mehmet, Ahiskali Rengin
Format: Artigo
Sprog:Inglês
Udgivet: BMC 2005-01-01
Serier:BMC Cancer
Online adgang:http://www.biomedcentral.com/1471-2407/5/10
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker